clinical trial · NCT04279314
Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome
Rett SyndromeTrofinetide
brief summary
To investigate the safety and tolerability of long-term treatment with oral trofinetide in girls and women with Rett syndrome
started
Jan 29, 2020
primary completion
Aug 19, 2022
completion
Aug 19, 2022
last updated
Apr 11, 2024
official title
A 40-Week, Open-label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol